Markets.com Logo

ABTS

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    3.9486$
  • Previous Close
    3.7451$
  • 52 Week Change
    9.15$
  • Day Range
    0.20$
  • 52 Week High/Low
    0.25$ - 9.4$
  • Dividend Per Share
    --
  • Market cap
    9 433 K$
  • EPS
    -0.15
  • Beta
    3.21
  • Volume
    --

About

ABTS.US is the stock ticker symbol for Abbots Laboratories listed on the U.S. stock exchange. Abbot Laboratories is a global healthcare company with a diverse portfolio of products including diagnostic systems, medical devices, nutritional products, and branded generic pharmaceuticals. Headquartered in Abbott Park, Illinois, the company serves people in approximately 160 countries. Investing in ABTS.US represents ownership in a portion of Abbots Laboratories and its future performance.

Morgan Stanley: US Job Growth Slowdown Signals a Bottom, Not Recession

Ava Grace|--

Will a Fed Rate Cut Save the US Stock Market from its Historic September Slump?

Noah Lee|--

UK Debt Crisis: A Canary in the Coal Mine for Other Economies?

Noah Lee|--

Ruchir Sharma Warns: Fed Rate Cuts Could Be a Grave Mistake Now

Liam James|--
TSLA Stock Analysis: Why Is Tesla Stock Rising Again?

TSLA Stock Analysis: Why Is Tesla Stock Rising Again?

Ghko B|--
NVDA Stock Drops Today: Why Nvidia Stock Is Trading Down Today?

NVDA Stock Drops Today: Why Nvidia Stock Is Trading Down Today?

Ghko B|--
 XRP Price Prediction: Will Ripple (XRP) Price Drop Toward $2?

XRP Price Prediction: Will Ripple (XRP) Price Drop Toward $2?

Frances Wang|--

Factors

[Company Performance]: ABTS.US's financial results (revenue, earnings, profit margins) and operational efficiency directly influence investor sentiment. Positive performance typically leads to higher stock prices.

[Industry Trends]: The overall health and growth prospects of the biotechnology and pharmaceutical industries, which ABTS.US operates in, affect investor confidence and valuation.

[Regulatory Environment]: Changes in regulations related to drug approvals, pricing, and clinical trials can significantly impact ABTS.US's ability to bring products to market and generate revenue.

[Clinical Trial Results]: The success or failure of clinical trials for ABTS.US's drug candidates is a major driver of stock price fluctuations. Positive results often lead to price increases.

[Competition]: The competitive landscape within the biotechnology and pharmaceutical sectors, including the emergence of new therapies or competitors, affects ABTS.US's market share and profitability.

[Market Sentiment]: Broad market trends and investor risk appetite can influence the demand for ABTS.US's stock. Bull markets tend to lift all stocks, while bear markets can depress prices.

[Economic Conditions]: Macroeconomic factors such as interest rates, inflation, and economic growth can impact ABTS.US's cost of capital, consumer spending on healthcare, and overall business environment.

[Mergers and Acquisitions]: Potential or actual merger or acquisition activity involving ABTS.US or its competitors can create significant price volatility due to speculation and changes in market structure.

People Also Watch

Latest news

Trump's Conflicts of Interest: How His Empire Benefits from the Presidency?

Sophia Claire|--

Betsent's Tightrope Walk: Navigating Fed Chair Selection Under Trump's Watch

Sophia Claire|--

US Job Growth Revision: Potential Impact on Fed Policy

Ava Grace|--

Latest Education Articles

VOO Price Today: How to Trade Vanguard S&P 500 ETF (VOO) CFD?

VOO Price Today: How to Trade Vanguard S&P 500 ETF (VOO) CFD?

Frances Wang|--
Major US Stock Exchanges Comparison: NYSE, NASDAQ

Major US Stock Exchanges Comparison: NYSE, NASDAQ

Frances Wang|--
Hang Seng Index Is Up Today: How to Trade HSI Index CFDs?

Hang Seng Index Is Up Today: How to Trade HSI Index CFDs?

Frances Wang|--